Champions Oncology Inc Q4 2025 Earnings Call Transcript - Thomson StreetEvents

Champions Oncology Inc Q4 2025 Earnings Call Transcript

Champions Oncology Inc Q4 2025 Earnings Call Transcript - Thomson StreetEvents
Champions Oncology Inc Q4 2025 Earnings Call Transcript
Published Jul 23, 2025
7 pages (4015 words) — Published Jul 23, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of CSBR.OQ earnings conference call or presentation 23-Jul-25 8:30pm GMT

  
Brief Excerpt:

...Operator Greetings. Welcome to the Champions Oncology fourth quarter fiscal year 2025 earnings call. (Operator Instructions) Please note this conference is being recorded. I will now turn the conference over to your host, Ronnie Morris, Chief Executive Officer. You may begin. Ronnie Morris ...

  
Report Type:

Transcript

Source:
Company:
Champions Oncology Inc
Ticker
CSBR.OQ
Time
8:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Matthew Hewitt - Craig-Hallum Holdings LLC - Analyst : Good afternoon and congratulations on the improved year. But before I have my questions, Ronnie, it's been nice working with you and best wishes in your new role at Champions. As far as the first question, and you kind of teased this a little bit in your prepared remarks, but the current environment, obviously, '24 was a very challenging environment. We've seen hints that maybe this calendar year is going to show some improvement. You noted that you've seen a decline in cancellations. I'm just wondering if you could maybe provide a little bit more color on what you're seeing in the current environment and what your expectations are for fiscal '26?


Question: Matthew Hewitt - Craig-Hallum Holdings LLC - Analyst : That's very helpful. And then kind of just moving down the list here, the data licensing opportunity, another little win here this quarter or follow-on. I'm just wondering what that pipeline looks like. What your expectations are for contribution in fiscal '26?


Question: Matthew Hewitt - Craig-Hallum Holdings LLC - Analyst : Got it. And then maybe one last one, and I'll hop back in the queue. But the new radiopharmaceutical service opportunity, what will those agreements look like? Size? Margins? Any color that you could provide there would be helpful. Thank you.


Question: Matthew Hewitt - Craig-Hallum Holdings LLC - Analyst : All right. Thanks. If no one else is going to jump in. Maybe first up, how should we be thinking about the capital allocation, obviously, a nice improvement this year versus last year. You're now sitting with a healthy amount of cash. But where do you see investments necessary to drive additional growth going forward?


Question: Matthew Hewitt - Craig-Hallum Holdings LLC - Analyst : Got it. And then I guess kind of on the data side and some of the work that you have previously done with your Corellia AI, are you still pursuing partnered programs there? Or any updates you could provide would be helpful.

Table Of Contents

Champions Oncology Inc Q2 2026 Earnings Call Transcript – 2025-12-15 – US$ 54.00 – Edited Transcript of CSBR.OQ earnings conference call or presentation 15-Dec-25 9:30pm GMT

Champions Oncology Inc Q1 2026 Earnings Call Transcript – 2025-09-15 – US$ 54.00 – Edited Transcript of CSBR.OQ earnings conference call or presentation 15-Sep-25 8:30pm GMT

Champions Oncology Inc Q3 2025 Earnings Call Transcript – 2025-03-11 – US$ 54.00 – Edited Transcript of CSBR.OQ earnings conference call or presentation 11-Mar-25 8:30pm GMT

Champions Oncology Inc Q2 2025 Earnings Call Transcript – 2024-12-11 – US$ 54.00 – Edited Transcript of CSBR.OQ earnings conference call or presentation 11-Dec-24 9:30pm GMT

Champions Oncology Inc Q1 2025 Earnings Call Transcript – 2024-09-11 – US$ 54.00 – Edited Transcript of CSBR.OQ earnings conference call or presentation 11-Sep-24 8:30pm GMT

Champions Oncology Inc Q3 2024 Earnings Call Transcript – 2024-03-12 – US$ 54.00 – Edited Transcript of CSBR.OQ earnings conference call or presentation 12-Mar-24 8:30pm GMT

Champions Oncology Inc Q1 2024 Earnings Call Transcript – 2023-09-13 – US$ 54.00 – Edited Transcript of CSBR.OQ earnings conference call or presentation 13-Sep-23 8:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Champions Oncology Inc Q4 2025 Earnings Call Transcript" Jul 23, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2025-Champions-Oncology-Inc-Earnings-Call-T16442466>
  
APA:
Thomson StreetEvents. (2025). Champions Oncology Inc Q4 2025 Earnings Call Transcript Jul 23, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2025-Champions-Oncology-Inc-Earnings-Call-T16442466>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.